Abstract
Angiotensin-converting enzyme-related carboxypeptidase (ACE2) is a recently identified zinc metalloprotease with carboxypeptidase activity that was identified using our genomics platform. We implemented a rational design approach to identify potent and selective ACE2 inhibitors. To this end, picomolar inhibitors of ACE2 were designed and synthesized.
MeSH terms
-
Angiotensin-Converting Enzyme 2
-
Angiotensin-Converting Enzyme Inhibitors / chemical synthesis
-
Angiotensin-Converting Enzyme Inhibitors / chemistry*
-
Angiotensin-Converting Enzyme Inhibitors / pharmacology*
-
Carboxypeptidases / antagonists & inhibitors*
-
Catalysis
-
Drug Design
-
Imidazoles / chemical synthesis
-
Imidazoles / chemistry*
-
Imidazoles / pharmacology
-
Peptidyl-Dipeptidase A
-
Protein Structure, Tertiary
-
Structure-Activity Relationship
-
Succinates / chemical synthesis
-
Succinates / chemistry
-
Succinates / pharmacology
Substances
-
Angiotensin-Converting Enzyme Inhibitors
-
Imidazoles
-
Succinates
-
benzylsuccinic acid
-
Carboxypeptidases
-
Peptidyl-Dipeptidase A
-
Angiotensin-Converting Enzyme 2